64 /100
HIGH RISK
Score updated May 30, 2026

ICU — SeaStar Medical Holding Corporation Dilution Risk Tracker

Track ICU dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ICU — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
65
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
35%
📉 Score Deterioration 50%
• Score rose 44 points recently (worsening)
• Score in HIGH risk zone (64/100)
💰 Capital Raise 35%
• Under 12 months cash (12mo)
• Active shelf registration ($15M, 101% of market cap)
🔔 Track ICU — Get forecast alerts →

💹 Market Data

Market Cap$14.83M
Shares Outstanding4.00M
Float3.95M
Cash$9.35M
Debt$331.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 27.2% shares (2025Q4 vs prior)
19 institutional holders · 797.8K shares
#1 VANGUARD GROUP INC 377.4K shares
#2 JANE STREET GROUP, LLC 126.9K shares
#3 Trinity Financial Advisors LLC 75.0K shares
+ 16 more holders Sign up free to view →

📉 Short Interest

Short Interest154.9K
Days to Cover1.7
% of Float3.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2025
S-1 SHELF Apr 28, 2026
4 INSIDER TRANSACTION Feb 10, 2026
4 INSIDER TRANSACTION Feb 10, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ICU Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ICU — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ICU
📊 ICU FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ICU Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.